ondansetron has been researched along with Hydrocephalus, Normal Pressure in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Hydrocephalus, Normal Pressure: A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder (see GAIT DISORDERS, NEUROLOGIC), progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp631-3)
Excerpt | Relevance | Reference |
---|---|---|
"Ondansetron was the only medication administered that had previously been associated with dystonic reactions." | 1.42 | Dystonic reaction associated with ondansetron administration in a patient with normal pressure hydrocephalus. ( Diaz-Parlet, J; Subramani, S, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diaz-Parlet, J | 1 |
Subramani, S | 1 |
1 other study available for ondansetron and Hydrocephalus, Normal Pressure
Article | Year |
---|---|
Dystonic reaction associated with ondansetron administration in a patient with normal pressure hydrocephalus.
Topics: Aged; Anesthesia, General; Dystonia; Female; Humans; Hydrocephalus, Normal Pressure; Intracranial Pr | 2015 |